A new lens on Alzheimer's disease: Insights into the Edinger-Westphal nucleus and its circuits

Alzheimer's disease (AD) is the primary cause of dementia, and as the population ages, the number of individuals affected by the disease continues to rise. However, effective treatments for AD are still lacking. In the initial stages of AD, many brain regions are susceptible to its characteristic pathological changes, such as the Edinger-Westphal nucleus (EW nucleus) located in the midbrain region, which functions primarily as the parasympathetic oculomotor nucleus regulating pupil constriction. In this review, we outline the characteristics of EW nucleus alterations in AD and their potential role in the disease's onset and progression from various perspectives, including molecular changes, pathological alterations, and synaptic circuits. We propose that cognitive functions governed by the EW nucleus and its associated circuits may undergo early changes in AD and could serve as potential targets for the early diagnosis and therapeutic development of AD.

• Publication year

  2025

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2025-09-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/13872877251372587PMID 40934150
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholecystokinin B receptor agonists alleviates anterograde amnesia in cholecystokinin-deficient and aged Alzheimer's disease mice

  2024cited by this paper
• The structural and functional complexity of the integrative hypothalamus

  2023cited by this paper
• Circadian modulation by time-restricted feeding rescues brain pathology and improves memory in mouse models of Alzheimer's disease.

  2023cited by this paper
• Cholecystokinin Signaling can Rescue Cognition and Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease

  2023cited by this paper
• The Role of BDNF in Multiple Sclerosis Neuroinflammation

  2023cited by this paper
• Stress regulates Alzheimer's disease progression via selective enrichment of CD8+ T cells.

  2023cited by this paper
• Intermittent fasting protects against Alzheimer’s disease in mice by altering metabolism through remodeling of the gut microbiota

  2022cited by this paper
• Entorhinal cortex dysfunction in Alzheimer's disease.

  2022cited by this paper
• Investigation of Anxiety- and Depressive-like Symptoms in 4- and 8-Month-Old Male Triple Transgenic Mouse Models of Alzheimer’s Disease

  2022cited by this paper
• Medial entorhinal cortex commissural input regulates the activity of spatially and object-tuned cells contributing to episodic memory.

  2022cited by this paper
• Pupil size as an indicator of cognitive activity in mild Alzheimer’s disease

  2022cited by this paper
• Neurodegeneration in the centrally-projecting Edinger–Westphal nucleus contributes to the non-motor symptoms of Parkinson’s disease in the rat

  2022cited by this paper
• Edinger-Westphal peptidergic neurons enable maternal preparatory nesting

  2022influential reference
• Peptidergic neurons of the Edinger–Westphal nucleus express TRPA1 ion channel that is downregulated both upon chronic variable mild stress in male mice and in humans who died by suicide

  2022cited by this paper
• Peptidergic modulation of fear responses by the Edinger-Westphal nucleus

  2021cited by this paper
• The Amyloid-β Pathway in Alzheimer’s Disease

  2021cited by this paper
• CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β-amyloid metabolism-associated enzymes

  2021cited by this paper
• The Relationship Between Anxiety and Alzheimer’s Disease

  2021cited by this paper
• Chronic stress and Alzheimer's disease: the interplay between the hypothalamic–pituitary–adrenal axis, genetics and microglia

  2021cited by this paper
• Vesicular glutamate transporter 2-containing neurons of the centrally-projecting Edinger-Westphal nucleus regulate alcohol drinking and body temperature.

  2021cited by this paper
• Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer's Disease Genetics.

  2020cited by this paper
• Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease

  2020cited by this paper
• Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

  2020cited by this paper
• Unsuspected Involvement of Spinal Cord in Alzheimer Disease

  2020cited by this paper
• Cholecystokinin and Alzheimer's disease: a biomarker of metabolic function, neural integrity, and cognitive performance.

  2019cited by this paper
• Impairments of attention in Alzheimer's disease.

  2019cited by this paper
• Selective Activation of Cholecystokinin-Expressing GABA (CCK-GABA) Neurons Enhances Memory and Cognition

  2019cited by this paper
• Pupillary light reflex circuits in the macaque monkey: the preganglionic Edinger–Westphal nucleus

  2019cited by this paper
• Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimer’s disease and stress disorders

  2019cited by this paper
• Alzheimer’s disease: risk factors and potentially protective measures

  2019cited by this paper
• The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.

  2018cited by this paper
• Ethanol Alters APP Processing and Aggravates Alzheimer-Associated Phenotypes

  2018cited by this paper
• Anxiety as a risk factor of Alzheimer's disease and vascular dementia

  2018cited by this paper
• Current understanding of Alzheimer’s disease diagnosis and treatment

  2018cited by this paper
• Serotonin receptor 2c-expressing cells in the ventral CA1 control attention via innervation of the Edinger–Westphal nucleus

  2018influential reference
• Pupil-size asymmetry is a physiologic trait related to gender, attentional function, and personality

  2017cited by this paper
• Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.

  2017cited by this paper
• Viewpoints: how the hippocampus contributes to memory, navigation and cognition

  2017cited by this paper
• How Hippocampal Memory Shapes, and Is Shaped by, Attention

  2017cited by this paper
• CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice

  2017cited by this paper
• Control of chronic excessive alcohol drinking by genetic manipulation of the Edinger–Westphal nucleus urocortin-1 neuropeptide system

  2017cited by this paper
• Pupil Size Tracks Attentional Performance In Attention-Deficit/Hyperactivity Disorder

  2017cited by this paper
• Neuroanatomy, Edinger–Westphal Nucleus (Accessory Oculomotor Nucleus)

  2017cited by this paper
• Prefrontal Parvalbumin Neurons in Control of Attention

  2016cited by this paper
• World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future

  2016cited by this paper
• Alzheimer's disease

  2016cited by this paper
• Spinal Cord Functional Anatomy

  2015cited by this paper
• A central mesencephalic reticular formation projection to the Edinger–Westphal nuclei

  2015cited by this paper
• The centrally projecting Edinger-Westphal nucleus--I: Efferents in the rat brain.

  2015cited by this paper
• CART treatment improves memory and synaptic structure in APP/PS1 mice

  2015cited by this paper
• Alzheimer's disease

  2015cited by this paper
• The stress response neuropeptide CRF increases amyloid‐β production by regulating γ‐secretase activity

  2015cited by this paper
• Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.

  2015cited by this paper
• High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology

  2014cited by this paper
• Dendritic and spinal alterations of neurons from Edinger-Westphal nucleus in Alzheimer's disease.

  2014cited by this paper
• Mouse strain and brain region‐specific expression of the glutaminyl cyclases QC and isoQC

  2014cited by this paper
• Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice

  2014cited by this paper
• Pupil fluctuations track fast switching of cortical states during quiet wakefulness.

  2014cited by this paper
• Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice

  2014cited by this paper
• Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging

  2014cited by this paper
• Role of Bed Nucleus of the Stria Terminalis Corticotrophin-Releasing Factor Receptors in Frustration Stress-Induced Binge-Like Palatable Food Consumption in Female Rats with a History of Food Restriction

  2014cited by this paper
• A putative relay circuit providing low-threshold mechanoreceptive input to lamina I projection neurons via vertical cells in lamina II of the rat dorsal horn

  2014cited by this paper
• The Distribution of Phosphorylated Tau in Spinal Cords of Alzheimer's Disease and Non-Demented Individuals

  2013cited by this paper
• Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease

  2013cited by this paper
• Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers.

  2013cited by this paper
• Impairment of nesting behaviour in 3xTg-AD mice.

  2013cited by this paper
• The Edinger-Westphal nucleus II: Hypothalamic afferents in the rat.

  2013cited by this paper
• Early BDNF Treatment Ameliorates Cell Loss in the Entorhinal Cortex of APP Transgenic Mice

  2013cited by this paper
• Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease

  2013cited by this paper
• Three‐dimensional organization of local excitatory and inhibitory inputs to neurons in laminae III–IV of the spinal dorsal horn

  2013cited by this paper
• Stress‐induced anhedonia is associated with an increase in Alzheimer's disease‐related markers

  2012cited by this paper
• Impaired Satiation and Increased Feeding Behaviour in the Triple-Transgenic Alzheimer's Disease Mouse Model

  2012cited by this paper
• Alzheimer's disease: early diagnosis and treatment.

  2012cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Chronic Stress Exacerbates Tau Pathology, Neurodegeneration, and Cognitive Performance through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism in a Transgenic Mouse Model of Tauopathy

  2011cited by this paper
• Characterization of Genetic Differences within the Centrally Projecting Edinger–Westphal Nucleus of C57BL/6J and DBA/2J Mice by Expression Profiling

  2011cited by this paper
• Epidemiology of Alzheimer disease

  2011cited by this paper
• Apolipoprotein E in Alzheimer's disease and other neurological disorders.

  2011cited by this paper
• The Edinger‐Westphal nucleus: A historical, structural, and functional perspective on a dichotomous terminology

  2011influential reference
• Restraint stress and repeated corticotrophin-releasing factor receptor activation in the amygdala both increase amyloid-β precursor protein and amyloid-β peptide but have divergent effects on brain-derived neurotrophic factor and pre-synaptic proteins in the prefrontal cortex of rats.

  2011cited by this paper
• Dendritic Pathology and Spinal Loss in the Visual Cortex in Alzheimer's Disease: A Golgi Study in Pathology

  2011cited by this paper
• The three stages of Alzheimer's disease.

  2011cited by this paper
• Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity.

  2010cited by this paper
• Severe Motor Neuron Degeneration in the Spinal Cord of the Tg2576 Mouse Model of Alzheimer Disease

  2010cited by this paper
• Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease.

  2010cited by this paper
• Distinct glutaminyl cyclase expression in Edinger–Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Aβ pathology in Alzheimer’s disease

  2010cited by this paper
• Alzheimer's disease: strategies for disease modification

  2010cited by this paper
• Restraint stress alters the secretory activity of neurons co-expressing urocortin-1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 in the mouse Edinger-Westphal nucleus.

  2010cited by this paper
• The worldwide societal costs of dementia: Estimates for 2009

  2010cited by this paper
• Effects of maternal separation on dynamics of urocortin 1 and brain‐derived neurotrophic factor in the rat non‐preganglionic Edinger‐Westphal nucleus

  2009cited by this paper
• Sex-specific effects of fasting on urocortin 1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 expression in the rat Edinger-Westphal nucleus.

  2009cited by this paper
• Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress

  2009cited by this paper
• Entorhinal cortex and cognition.

  2009cited by this paper
• Ultrastructural and immunocytochemical characterization of the rat non-preganglionic Edinger-Westphal nucleus.

  2009cited by this paper
• Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease.

  2009cited by this paper
• Cognitive and non‐cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer’s disease

  2009cited by this paper
• Sex-specific expression of BDNF and CART in the midbrain non-preganglionic Edinger-Westphal nucleus in the rat.

  2009cited by this paper
• Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

  2009cited by this paper
• Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease

  2009influential reference
• Development of tau aggregation inhibitors for Alzheimer's disease.

  2009cited by this paper

• No citing papers are available for this paper.